Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]. [electronic resource] by
- Lehmann, J
- Retz, M
- Steiner, G
- Albers, P
- Jaeger, E
- Knuth, A
- Lippert, C
- Koser, M
- Stockamp, K
- Otto, C
- Melchior, H
- Fassmann, C
- Potratz, C
- Loch, T
- Derigs, H G
- Becker, T
- Kälble, T
- Piechota, H-J
- Hertle, L
- Weinknecht, S
- Weissbach, L
- Al-Mwalad, M
- Hamza, A
- Henss, H
- Brkovic, D
- Pomer, S
- Roloff, J
- Walz, P
- Muschter, R
- Tunn, U
- Winter, E
- Bub, P
- Kaldenbach, U
- Roth, S
- Brauers, A
- Jakse, G
- Richter, A E
- Wirth, M
- Hartlapp, J
- Van Ahlen, H
- Stöckle, M
Producer: 20040223
In:
Der Urologe. Ausg. A vol. 42
Availability: No items available.
|